Clinical Trial

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To further explore the application prospects of integrated Traditional Chinese and Western medicine in chronic disease prevention and control and health management, this study intends to establish a large, prospective, integrated Traditional Chinese and Western medicine cohort in Hubei Province. This study will conduct long-term follow-up and multi-dimensional data collection to systematically reveal the associations between Traditional Chinese Medicine (TCM) constitution types and chronic diseases, the aging process, and multi-morbidity, thereby developing an integrated health management strategy with local characteristics. This study will fill the current gap in systematic evidence linking TCM constitutions to the prevalence of modern diseases, providing a solid demographic and biological foundation for the integrated development of Traditional Chinese and Western medicine. It will also contribute to meeting the needs for early disease warning, early intervention, and personalized care under the "Healthy China" strategic goal.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-20.
Trial Details
NCT Number NCT07196917
Lead Sponsor Huazhong University of Science and Technology
Collaborators: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei College of Traditional Chinese Medicine, Hubei Hospital of Traditional Chinese Medicine, Hubei Provincial Center for Disease Control and Prevention, Wuhan Center for Disease Control and Prevention
Conditions Cardiovascular Diseases, Respiratory Tract Diseases, Cancer, Endocrine System Diseases, Death
Enrollment 1,000,000 participants
Start Date 2025-10-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-02